US Stock MarketDetailed Quotes

DWTX Dogwood Therapeutics

Watchlist
  • 2.850
  • +0.030+1.06%
Close Dec 30 16:00 ET
3.80MMarket Cap-0.45P/E (TTM)

About Dogwood Therapeutics Company

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Company Profile

SymbolDWTX
Company NameDogwood Therapeutics
Listing DateDec 17, 2020
Founded2012
CEOMr. Gregory Duncan
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address44 Milton Avenue
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30009
Phone1-866-620-8655
Websitehttp://www.dwtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Gregory Duncan
  • Chief Executive Officer and Chairman of the Board
  • 936.83K
  • Dr. Roger Michael Gendreau, M.D.,PhD
  • Chief Medical Officer
  • 566.18K
  • Angela Walsh
  • Chief Financial Officer, Corporate Secretary and Treasurer
  • 426.82K
  • Ralph Grosswald
  • Senior Vice President, Operations
  • --
  • Dr. Melvin Toh, PhD
  • Director
  • --
  • Ying Choi Alan Abel Yu
  • Director
  • --
  • Dr. Abel De La Rosa,PhD
  • Independent Director
  • 63.99K
  • John C. Thomas,Jr
  • Independent Director
  • 66.49K
  • David Keefer
  • Independent Director
  • 72.99K
  • Dr. William L. Pridgen, M.D.
  • Independent Director
  • 51.49K
  • Dr. Richard J. Whitley,M.D.
  • Independent Director
  • 64.49K
Heat List
US
Overall
Symbol
Price
% Chg

No Data